Merck's Keytruda likely to benefit from 'celebrity effect' after Jimmy Carter declared free of cancer

Former President Jimmy Carter has been declared free of cancer after receiving Merck's ($MRK) Keytruda and radiation therapy for his metastasized melanoma, and research shows that Merck is likely to get a boost in sales as a result. A number of studies have documented a proven celebrity effect in healthcare. One study showed after journalist Katy Couric had an on-air colonoscopy, there was a 21% increase in colorectal screenings the next month. Singer Kylie Minogue's breast cancer diagnosis was later linked to mammography screening increases of 40% in Australia. More from FiercePharmaMarketing

Suggested Articles

Cannes Lions Health kicks off Monday, and attendees are looking for some breakouts—leading-edge tech, creativity and inspiration, for instance.

Bluebird has priced gene therapy Zynteglo at €1.575 million in Europe and promised a U.S. price in “reasonably close” range.

Generic pain drug maker Lannett is closing its plant in Wyoming and laying off the remaining 80 employees.